UBS O'Connor’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-79,354
| Closed | -$117K | – | 507 |
|
|
2024
Q3 | $117K | Buy |
79,354
+7,371
| +10% | +$10.8K | ﹤0.01% | 372 |
|
|
2024
Q2 | $97.2K | Buy |
71,983
+1,586
| +2% | +$2.14K | ﹤0.01% | 398 |
|
|
2024
Q1 | $115K | Sell |
70,397
-22,303
| -24% | -$36.6K | ﹤0.01% | 381 |
|
|
2023
Q4 | $179K | Sell |
92,700
-86,380
| -48% | -$167K | 0.01% | 379 |
|
|
2023
Q3 | $430K | Hold |
179,080
| – | – | 0.01% | 396 |
|
|
2023
Q2 | $457K | Sell |
179,080
-33,960
| -16% | -$86.6K | 0.01% | 439 |
|
|
2023
Q1 | $347K | Buy |
+213,040
| New | +$347K | 0.01% | 477 |
|
|
2022
Q4 | – | Sell |
-60,650
| Closed | -$240K | – | 307 |
|
|
2022
Q3 | $240K | Buy |
+60,650
| New | +$240K | ﹤0.01% | 804 |
|